This hub covers epilepsy devices and neuromodulation like VNS, RNS, and DBS, which are treatments that can reduce seizures when meds aren’t enough. Plain-language research summaries plus real-life pros/cons.
Some are used more often in adults, but pediatric use depends on the device, the case, and specialist guidance.
Often gradually. Improvement can build over months as settings are optimized.
Sometimes medication can be reduced, but many people still use meds alongside a device.
Sometimes yes, with device-specific rules. Always check the exact device guidelines first.
This study looked at how adults with non-convulsive status epilepticus (NCSE) were treated in a 6-year ambispective registry, and whether treatment patterns were associated with seizure control, death in the hospital, or worse function at discharge.
This study looked at how often antipsychotic medicines were prescribed to children and teens with epilepsy in Uganda, and which medicines were used together.
Researchers looked at whether the brain’s activity just before an electrical stimulation pulse can help explain why the response to that pulse changes from one trial to the next.
This paper is a review, not a report of new patient results.
This study looked at outcomes of responsive neurostimulation (RNS) in people with Lennox-Gastaut syndrome (LGS), a severe epilepsy that is often hard to control with medicine.
This paper was a systematic review, which means the authors gathered and combined results from earlier studies.
This study was a systematic review with meta-analysis.
This study looked at cenobamate used as an add-on seizure medicine in children, teens, and young adults with drug-resistant epilepsy.
This paper was a review, not a new experiment.